Fig. 8From: SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathwayMechanism of SOCS5 inhibition of JAK2/STAT3 signaling pathwayBack to article page